About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Hspa12atm1.1Zdi
targeted mutation 1.1, Zhengnian Ding
MGI:6306701
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Hspa12atm1.1Zdi/Hspa12atm1.1Zdi involves: 129 * C57BL/6 MGI:6512419


Genotype
MGI:6512419
hm1
Allelic
Composition
Hspa12atm1.1Zdi/Hspa12atm1.1Zdi
Genetic
Background
involves: 129 * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hspa12atm1.1Zdi mutation (0 available); any Hspa12a mutation (39 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• reduced macrophage recruitment to liver when fed high fat diet (HFD)
• reduced M1 polarization of macrophages in liver when fed high fat diet (HFD)
• increased LPS-induced hepatocyte pyroptosis and liver damage
• lower body temperature and activity after LPS challenge
• increased LPS-induced macrophage and neutrophil recruitment to liver

nervous system
N
• normal brain weight
• significantly worse neurological score 24h after MCAO and reperfusion treatment
• significantly more severe neuronal morphological damage (shrinkage, nuclear pyknosis) in hippocampus 24h after MCAO and reperfusion treatment
• significantly more apoptotic cells in ventral and caudal peri-infarct areas 24h after middle cerebral artery occlusion (MCAO) and reperfusion treatment
• significantly slower recovery as determined by total distance moved and movement speed in open field test 20 days after MCAO and reperfusion treatment
• 80% reduction in neurogenesis in ischemic hemisphere and 70% in hippocampus 5 days after MCAO and reperfusion treatment
• ~50% increase in infarct volume 24h after middle cerebral artery occlusion (MCAO) and reperfusion treatment

liver/biliary system
• reduced HFD-induced steatosis
• reduced liver weight and hepatocyte size gain when fed high fat diet (HFD)
• normal liver weight, hepatocyte size and lipid amount on regular chow

hematopoietic system
• reduced macrophage recruitment to liver when fed high fat diet (HFD)
• reduced M1 polarization of macrophages in liver when fed high fat diet (HFD)

mortality/aging
• no high fat diet (HFD)-induced liver injury as determined by lack of elevated serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity when fed HFD
• reduced liver weight and hepatocyte size gain when fed high fat diet (HFD)
• normal liver weight, hepatocyte size and lipid amount on regular chow

growth/size/body
• reduced body mass gain an smaller iWAT adipocytes at age 16 weeks on regular chow
• normal body length and food intake at age 16 weeks on regular chow
• reduced body mass gain after 14 weeks on high fat diet (HFD)
• smaller inguinal white adipose tissue (iWAT), visceral WAT (vWAT) and mesenteric WAT (mWAT) depots after 14 weeks on HFD
• smaller adipocytes in iWAT after 14 weeks on HFD
• reduced increase in serum free fatty acid, LDL-C, HDL, cholesterol and glucose levels when fed HFD

homeostasis/metabolism
N
• normal glucose tolerance after 16h fasting (J:287930)
• normal lipid, glucose and fasting insulin levels in serum on regular chow (J:302786)
• reduced body mass gain after 14 weeks on high fat diet (HFD)
• smaller inguinal white adipose tissue (iWAT), visceral WAT (vWAT) and mesenteric WAT (mWAT) depots after 14 weeks on HFD
• smaller adipocytes in iWAT after 14 weeks on HFD
• reduced increase in serum free fatty acid, LDL-C, HDL, cholesterol and glucose levels when fed HFD
• in insulin tolerance test after 4h fasting
• significantly worse neurological score 24h after MCAO and reperfusion treatment
• significantly more severe neuronal morphological damage (shrinkage, nuclear pyknosis) in hippocampus 24h after MCAO and reperfusion treatment
• significantly more apoptotic cells in ventral and caudal peri-infarct areas 24h after middle cerebral artery occlusion (MCAO) and reperfusion treatment
• significantly slower recovery as determined by total distance moved and movement speed in open field test 20 days after MCAO and reperfusion treatment
• 80% reduction in neurogenesis in ischemic hemisphere and 70% in hippocampus 5 days after MCAO and reperfusion treatment
• ~50% increase in infarct volume 24h after middle cerebral artery occlusion (MCAO) and reperfusion treatment





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory